Drug capsules are seen on the production line at the plant of French multinational pharmaceutical company"Pierre Fabre", in Gien on March 21, 2018.Gizmodo issued a correction Thursday for a slightly inaccurate price of a surging anti-seizure medication. The company sent a tweet to correct the number at the request of the drug company, Mallinckrodt Pharmaceuticals, who raised the medication price nearly 100,000 percent.
Gizmodo formerly reported the price for the drug, Acthar—which is primarily used for infants with seizure symptoms—was raised from $40 to $40,000. The company, however, stressed that the true price of the drug is now $38,892. Gizmodo edited the article Thursday. The company's tweet specified that the request from a Mallinckrodt spokesperson was the reason for the slight number tweak."CORRECTION: Gizmodo originally stated that drug company Mallinckrodt had jacked up the price of an anti-seizure medication from $40 in 2000 to over $40,000 today," the tweet read."A spokesperson for Mallinckrodt emailed to request a correction that the drug costs $38,892.
An even sassier correction exists on the Gizmodo article. The statement reads the same with added lines:"Gizmodo regrets the error. We also regret that every last one of these guys isn't in prison yet." Readers commented sarcastically on the tweet, and implied that with a drug that costs close to $39,000, the extra $1,108 doesn't make a dramatic difference anyway.This medicine costs as much as a *slightly used* SUVGlad theyâve cleared this up. That extra $1,108 could be the difference between destitution and, well...destitution.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: CNBC - 🏆 12. / 72 続きを読む »